Multiple abscesses in a patient treated with cetuximab

Francesco Ricci, Cristina Guerriero, Andrea Paradisi, Barbara Fossati, Francesco Micciche', Vincenzo Valentini, Rodolfo Capizzi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Cetuximab, a chimeric monoclonal antibody againts epidermal growth factor receptor (EGFR), is increasingly used to treat tumors that overexpress this receptor as squamous cell cancer of the head and neck (SCCHN), colon and non-small-cell lung cancers. The most common side effects of anti-EGFR are acneiform rash, xerosis, paronychia, teleangiectasia and itch. We report the unusual case of a patient with SCCHN in whom treatment with cetuximab led to development of multiple cutaneous abscesses.
Original languageEnglish
Pages (from-to)103-104
Number of pages2
JournalEuropean Journal of Dermatology
Publication statusPublished - 2013


  • inglese


Dive into the research topics of 'Multiple abscesses in a patient treated with cetuximab'. Together they form a unique fingerprint.

Cite this